Alcohol producers and pubs are facing a potential new challenge as GLP-1 medications, widely used for weight loss and diabetes management, appear to be influencing drinking habits. Early research suggests that some users are drinking less, creating pressure for an industry already dealing with declining alcohol consumption in several major markets.

For pubs, the shift could mean adapting to changing customer preferences rather than relying primarily on alcohol sales. Smaller servings, lower-alcohol options and premium drinks may become increasingly important as consumers seek moderation and better-value social experiences.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Alcohol Producers Face Another Demand Challenge

The alcohol industry has been contending with years of declining consumption as health concerns and tighter household budgets encourage people to drink less. GLP-1 medications could add to that pressure.

Heineken said it had discussed the evolving market with UK hospitality businesses as part of its regular engagement with the sector. The brewer noted changes in consumption among GLP-1 users and said it would continue monitoring their behaviour in 2027.

According to Heineken, users are not necessarily giving up alcohol altogether. Instead, some are choosing smaller servings, lower-alcohol drinks and more premium products, reflecting wider trends in the market. The company believes its portfolio is positioned to meet these changing preferences.

UK Pubs Offer Room For Growth

Europe remains Heineken’s largest region by revenue, although growth has been sluggish. The UK has performed comparatively well, with the hospitality sector offering opportunities for the brewer.

A Heineken UK report found that beer generated nearly £14 billion in sales across British pubs, bars and restaurants in the year to February 2026. No- and low-alcohol beer accounted for less than £300 million of that total, indicating that these products still represent a relatively small share of the market.

If drinking habits continue to change, the balance between traditional beer and lower-alcohol alternatives could shift.

Early Data Points To Lower Alcohol Spending

Research is beginning to suggest that GLP-1 use may affect purchasing behaviour. Circana found that US households with at least one GLP-1 user reduced their alcohol spending between 2024 and 2026 compared with households without a user. After two years on the medications, monthly alcohol spending was around 7% lower, while spending on beer fell by approximately 13.5%.

Other major producers remain cautious about drawing firm conclusions. Diageo has told investors that the impact of GLP-1 drugs should remain manageable, even if their use expands. Carlsberg has said available data does not yet establish the medications as a clear driver of beer consumption trends, while Anheuser-Busch InBev declined to comment.

Surveys conducted in Europe and the UK by Circana, NIQ and KAM have also indicated that some GLP-1 users are drinking less.

Users Report Changes In Drinking Habits

In interviews with Reuters, 10 of 11 people taking GLP-1 medications said they had reduced their alcohol consumption, in some cases significantly. Some reported feeling unwell or uncomfortable after drinking, while others said their desire for alcohol had diminished.

Daniel Cornwell, a UK-based founder of hospitality recruitment firm SPE Resourcing, said he previously drank regularly at work events and on weekends. He now finds that alcohol leaves him feeling uncomfortable and can cause hangovers lasting several days.

Joseph Schacht, a professor at the University of Colorado Anschutz who led a randomised controlled trial examining GLP-1 medications and alcohol use disorder, said the drugs may affect brain mechanisms associated with the motivation to drink. He noted that trials involving people with alcohol use disorder have consistently found reductions in cravings and alcohol consumption.

Schacht described the medications as a potential “Prozac moment” for treating alcohol use disorder. However, if reduced cravings extend to a broader population, the trend could also create a challenge for alcohol producers as they adapt to changing consumer behaviour.